![August 2019: SEARCH trial on universal ART intervention shows some benefits, but HIV incidence not lower than with the standard of care](https://icap.columbia.edu/wp-content/uploads/august-jc-header-1080x675.png)
Journal Club
![August 2019: SEARCH trial on universal ART intervention shows some benefits, but HIV incidence not lower than with the standard of care](https://icap.columbia.edu/wp-content/uploads/august-jc-header-1080x675.png)
![July 2019: ECHO trial of three contraceptive methods finds no significant difference in HIV incidence but alarmingly high incidence overall](https://icap.columbia.edu/wp-content/uploads/echo-article-header-1080x675.png)
July 2019: ECHO trial of three contraceptive methods finds no significant difference in HIV incidence but alarmingly high incidence overall
Article and Study Summary HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial. Published in: The Lancet. Published...![May/June 2019: PARTNER study of 782 serodiscordant MSM couples shows zero transmissions of HIV while HIV-positive partner virally suppressed](https://icap.columbia.edu/wp-content/uploads/June-JC-header-1200x900-1080x675.png)
May/June 2019: PARTNER study of 782 serodiscordant MSM couples shows zero transmissions of HIV while HIV-positive partner virally suppressed
Article and Study Summary Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Published in:...![March/April 2019: BRIEF TB/A5279 Study suggests 1-month rifapentine/isoniazid regimen prevents TB in people living with HIV as well as standard 9-month isoniazid alone](https://icap.columbia.edu/wp-content/uploads/march-2019-jc-header-1080x675.png)
March/April 2019: BRIEF TB/A5279 Study suggests 1-month rifapentine/isoniazid regimen prevents TB in people living with HIV as well as standard 9-month isoniazid alone
Article and Study Summary One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Published in: N Engl J Med. 2019;380 (11):1001-1011. https://doi.org/10.1056/NEJMoa1806808. Authors: Swindells S, Ramchandani R, Gupta A, et al for the BRIEF...![February 2019: HPTN 071 (PopART) results show community-based distribution of HIV self-testing kits increases knowledge of HIV status, especially among men](https://icap.columbia.edu/wp-content/uploads/feb-2019-jc-header-7-1080x675.png)